Tyson Ritter, lead vocalist for the All-American Rejects, will ride in the Fastest Seat in Sports at the Java House Grand Prix of Monterey this Sunday, July 27. Ritter and his fellow bandmates have ...

After a tough few weeks for Sarepta Therapeutics Inc., the EMA dealt another blow on July 25, announcing it will not be ...

Sarepta has suffered another regulatory setback after the European Medicines Agency’s (EMA’s) Committee for Medicinal ...

Friday said that the European Medicines Agency has issued a negative opinion on the conditional marketing authorization for Elevidys, intended for ambulatory patients aged three to seven with Duchenne ...

Trump Administration Rejects New Rules Giving World Health Organization ‘Unprecedented Power’ RFK Jr. says the policy ‘lays the groundwork for global medical surveillance over every human being.’ ...

Shares of Sarepta Therapeutics plummeted Friday following a report that a third patient has died during a clinical trial for one of its medications.

The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still walk. A pause on shipments to older, non-ambulatory patients remains in ...

Sarepta led investors to believe that its ELEVIDYS therapy was both safe and had potential for approval in wider applications. The Company misled the market about its revenue outlook on ELEVIDYS.

Sarepta's gene therapy pipeline faces renewed scrutiny after a third patient death and FDA plans for a black box warning on Elevidys.

A South Korean court rejected ousted former President Yoon Suk Yeol's request to be freed from prison on Friday, Newsis news agency said, denying his argument that his detention during an ...

Sarepta rebuffed a call from the Food and Drug Administration to halt all shipments of its gene therapy for Duchenne muscular dystrophy over safety issues, even as patients and investors expressed ...